Study 3: STEP 5 Trial Duration : 104 weeks (2 years) Findings : Participants on semaglutide lost an average of 15.2% of their body weight, compared to 2.6% in the placebo group
( C H ) Representative high-power immunofluorescence images of the AP and NTS stained for PrRP alone, or with GLP-1R or TH, and counterstained with DAPI nuclear stain
Side effects of Wegovy include nausea, vomiting, abdominal pain, loss of appetite, diarrhea, or constipation may occur
Week 2 Finding your rhythm Youll start your medication with guidance from your care team, and begin tracking how your body responds
The STEP trial program, which studied semaglutide 2.4 mg for weight management, told the same story